Drug Trial News

RSS

New test identifies patients who benefit from targeted cancer drugs

New lab test accurately identified patients who would benefit from treatment with the molecularly-targeted anti-cancer therapies gefitinib (Iressa, AstraZeneca) and erlotinib (Tarceva, Genentech).

13 Jun 2006

Parkinson's patients stomach new drug better than conventional meds

Several studies conducted at Baylor College of Medicine (BCM) in Houston show that a new kind of orally disintegrating tablets provides improved symptom relief for patients with Parkinson's disease.

13 Jun 2006

Duloxetine proven effective for use in men with stress urinary incontinence after radical prostatectomy

Up to 33% of patients undergoing radical prostatectomy suffer from varying degrees of incontinence.

13 Jun 2006

The n-of-1 trial: An opportunity for complementary and alternative medicine evaluation

It is an extremely interesting rationale for the use of n-of-1 randomized trials, particularly for complementary and alternative medicine evaluation in the treatment of chronic, difficult to treat disorders.

13 Jun 2006

Predictive model of prostate cancer risk

Combining PSA with other risk factors for prostate cancer (CaP) may result in individualized risk prediction.

13 Jun 2006

Are we over-dosing on antibiotics?

Dutch researchers say that a three day course of antibiotics is just as effective as the usual seven to 10 days course when it comes to treating common pneumonia.

12 Jun 2006

Diabetes figures all set to blow out by 2050

Researchers who carried out a study of diabetes are predicting that by the year 2050 there will be 39 million with the disease in the United States.

12 Jun 2006

Folic acid may be the new cancer prevention therapy

According to a new study supplements of folic acid may help prevent cancer.

12 Jun 2006

When it comes to diabetes doctors failing to follow 'doctors orders'

According to the latest reports when it comes to diabetes and following doctors orders, doctors are failing their patients.

12 Jun 2006

New drug helps diabetics keep their sight

Trials of an experimental drug which helps slow down the loss of vision caused by diabetes have had very optimistic results.

12 Jun 2006

Bortezomib extends lung cancer survival

Adding the new molecularly targeted agent bortezomib to a standard chemotherapy regimen of gemcitabine and carboplatin prolongs survival in patients with advanced non-small cell lung cancer, according to results from a phase II trial.

9 Jun 2006

Radionuclide therapy with chemotherapy effective in treating prostate cancer

A new treatment for prostate cancer may provide a distinct advantage over other conventional protocols and induce actual regression of the disease - not just relief from bone pain or a limited control of the disease.

9 Jun 2006

Love-hate relationships

People who see their relationships as either all good or all bad tend to have low self-esteem, according to a series of seven studies by Yale researchers published in the Journal of Personality and Social Psychology.

9 Jun 2006

Benefits of naps for medical residents

The first study to assess the benefits of naps for medical residents during extended shifts found that creating protected times when interns could sleep during a night on-call significantly reduced fatigue.

8 Jun 2006

What is the optimal duration of antibiotic therapy?

Taking antibiotics for three days is just as effective for community acquired pneumonia as continuing treatment for the recommended 7-10 days, finds a study in this week's British Medical Journal.

8 Jun 2006

Liquorice compounds could be a key component for cheaper, more effective liver cancer treatment

Liquorice compounds could be a key component for cheaper, more effective liver cancer treatment, reports Chemistry & Industry magazine.

8 Jun 2006

Popular hypertension drugs triple the risk of birth defects

A study by American researchers has found that certain widely used hypertension drugs, once considered safe in the early stages of pregnancy, can almost triple the risk of birth defects.

8 Jun 2006

Sunitinib shows promise in treating metastatic renal cell cancer

A new study suggests that sunitinib is a promising agent for treatment of metastatic renal cell cancer, currently a disease without highly effective treatment options, according to an article in the June 7 issue of the Journal of the American Medical Association.

7 Jun 2006

How many men have osteoporosis?

Though it's much more common in women, osteoporosis can strike men too, often with debilitating consequences.

7 Jun 2006

Lessons from our patients: development of a warm autopsy program

Thanks in large part to a dying patient's generosity, researchers have for the first time begun to analyze the progression of idiopathic pulmonary fibrosis (IPF), a degenerative illness distinguished by lung inflammation, scarring and diminished breathing capacity that typically leads to death within about five years of diagnosis.

7 Jun 2006